Bleakley Financial Group »

Pyxis Oncology shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $20k 11k 1.80
2023-09-30 $22k 11k 1.99
2023-03-31 $73k 18k 4.01

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Bleakley Financial Group

Top funds holding Pyxis Oncology

Laurion Capital Management
Balyasny Asset Management
Ikarian Capital
Vanguard Group
Standard Life Aberdeen
Millennium Management
Superstring Capital Management
Boothbay Fund Management
Monashee Investment Management
Hillhouse Capital Advisors
Geode Capital Management
Goldman Sachs Group
Decheng Capital
BlackRock
Bridgeway Capital Management

View all funds holding Pyxis Oncology